Mechanism of Action of Pfizer-BioNTech Coronavirus Vaccine Revealed

Strategic Insights -

Researchers have made a significant discovery in the mechanism of action of the Pfizer-BioNTech coronavirus vaccine, which demonstrated 95% efficacy in preventing against SARS-CoV-2 infection. However, the precise mechanisms underlying its effectiveness remained poorly understood until now. A recent study has investigated the early immune responses in the draining lymph node (dLN) and its role in mediating antiviral protection following vaccination. The study has shed light on the involvement of antigen-presenting cells (APCs) in adaptive immunity, revealing a crucial role of plasmacytoid dendritic cells (pDCs) in mediating both adaptive and humoral responses to the vaccine.

Key Takeaways:

  • The Pfizer-BioNTech coronavirus vaccine is rapidly transported to the draining lymph node (dLN) and is primarily captured by leukocytes that initiate the expression of the viral antigenic spike protein.
  • Plasmacytoid dendritic cells (pDCs) play a key role in mediating both adaptive and humoral responses to the vaccine, as their specific depletion led to impaired antibody production and diminished neutralization capacity.
  • pDCs interact with CD8+ T cells, facilitating T cell activation, and in vivo experiments confirmed that pDCs expressing the viral spike protein directly engage with CD8+ T cells, promoting their differentiation and expansion.
  • The absence of pDCs affected the formation of antigen-specific memory T cells, highlighting the essential role of pDCs in mediating antiviral protection following vaccination.
  • The study provides new insights into the mechanistic functioning of mRNA vaccines and establishes a novel role for pDCs as professional APCs.
  • The Pfizer-BioNTech coronavirus vaccine demonstrated 95% efficacy in preventing against SARS-CoV-2 infection.

Statistics:

  • The Pfizer-BioNTech coronavirus vaccine resulted in 95% efficacy in preventing against SARS-CoV-2 infection.
  • The study involved the analysis of single-cell transcriptomic data, revealing an interaction between pDCs and CD8+ T cells.
  • In vivo experiments confirmed that pDCs expressing the viral spike protein directly engage with CD8+ T cells, promoting their differentiation and expansion.

Sources:

  • biorxiv.org (2025.06.13.659539v1)
  • World Health Organisation (WHO)